肿瘤坏死因子相关调亡诱导配基在肺动脉高压中的表达与临床意义  

The expression and clinical significance of TRAIL in pulmonary artery hypertension

在线阅读下载全文

作  者:杨二丽[1] 左曹建[1] 何玉虎[1] 孙佳腾[1] 吕安康[1] 

机构地区:[1]上海交通大学医学院附属瑞金医院心血管内科,上海200025

出  处:《诊断学理论与实践》2013年第3期330-333,共4页Journal of Diagnostics Concepts & Practice

基  金:"十一五"国家科技支撑计划重大项目课题(30871027)

摘  要:目的:探索肿瘤坏死因子相关调亡诱导配基(TRAIL)在肺动脉高压(PAH)中的表达及其临床意义。方法:入选2009年至2012年间就诊于瑞金医院门诊或住院部的患者82例,分为2组,心脏彩超检查诊断为PAH的患者27例作为PAH组,非PAH患者55例作为对照组。用ELISA法测定其血清TRAIL水平,结合世界卫生组织功能分级(WHO-FC)和六分钟步行距离(6MWD)等临床资料进行统计学分析。结果:与对照组相比较,PAH患者的血清TRAIL水平显著增高[(131.20±60.44)pg/mL比(77.28±26.84)pg/mL,P<0.001]。在PAH组中,血清TRAIL水平,①WHO-FCⅢ级和Ⅳ级的患者明显高于WHO-FCⅠ级和Ⅱ级者[(155.25±49.93)pg/mL比(74.08±43.12)pg/mL,P<0.001)];②与6MWD呈线性相关(r=-0.544,P=0.044),而与肺动脉收缩压(PASP)间无相关性。结论 :PAH患者血清TRAIL明显升高,且与疾病的严重程度相关。Objective: To investigate the expression and clinical significance of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in pulmonary arterial hypertension (PAH). Methods: Eighty-two patients from outpatient or inpatient department of Ruijin hospital from 2009 to 2012 were enrolled and stratified into 2 groups: PAH group, 27 patients diagnosed by echocardiography; control group, 55 non-PAH patients. Serum TRAIL was assessed by EL|SA and the results were analyzed with the World Health Organization (WHO) functional classification (WHO - FC) and six minutes walking distance (6 MWD). Results: Level of TRAIL in PAH group was significantly higher than that of the control group [(131.20±60.44) pg/mL vs (77.28±26.84) pg/mL, P=0.O00)]. In PAH group, serum TRAIL level in the WHO FC m and 1V was significantly higher than that of I and lI [(155.25±49.93) pg/mL vs (74.08±43.12) pg/mL, P〈0.001)]. There was a linear correlation (r=-0.544, P=0.044) between level of serum TRAIL and 6 MWD, but no significant correlation was seen with pulmonary artery systolic pressure (PASP). Conclusions: Serum TRAIL increases significantly in PAH patients and correlates with the severity of disease.

关 键 词:肺动脉高压 肿瘤坏死因子相关调亡诱导配基 WHO功能分级 六分钟步行距离 肺动脉收缩压 

分 类 号:R543.2[医药卫生—心血管疾病]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象